Smith Nicholas Conrad
Reporting owner on Forms 3, 4 and 5, CIK 2009130.
Smith Nicholas Conrad reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Alto Neuroscience, Inc. CIK 1999480 | officer (PRESIDENT AND CFO) | 2 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Alto Neuroscience, Inc. Common Stock | 2026-10-02 | M exercised | +55,000 | $2.32 | 79,060 | Form 4 |
| Alto Neuroscience, Inc. Employee Stock Option (Right to Buy), derivative | 2026-10-02 | M exercised | -55,000 | $0 | 57,405 | Form 4 |
| Alto Neuroscience, Inc. Common Stock | 2026-09-30 | M exercised | +24,056 | $2.35 | 48,116 | Form 4 |
| Alto Neuroscience, Inc. Common Stock | 2026-09-30 | S sold | -23,170 | $25.7786 | 24,946 | Form 4 |
| Alto Neuroscience, Inc. Common Stock | 2026-09-30 | S sold | -886 | $26.87 | 24,060 | Form 4 |
| Alto Neuroscience, Inc. Employee Stock Option (Right to Buy), derivative | 2026-09-30 | M exercised | -24,056 | $0 | 121,818 | Form 4 |
| Alto Neuroscience, Inc. Common Stock | 2026-09-29 | M exercised | +56,455 | $2.35 | 80,515 | Form 4 |
| Alto Neuroscience, Inc. Common Stock | 2026-09-29 | M exercised | +54,375 | $2.35 | 134,890 | Form 4 |
| Alto Neuroscience, Inc. Common Stock | 2026-09-29 | S sold | -110,830 | $26.5826 | 24,060 | Form 4 |
| Alto Neuroscience, Inc. Employee Stock Option (Right to Buy), derivative | 2026-09-29 | M exercised | -56,455 | $0 | 145,874 | Form 4 |
| Alto Neuroscience, Inc. Employee Stock Option (Right to Buy), derivative | 2026-09-29 | M exercised | -54,375 | $0 | 35,625 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002009130-26-000006 | Alto Neuroscience, Inc. | 2026-10-05 | ||
| Form 4 0002009130-26-000004 | Alto Neuroscience, Inc. | 2026-10-01 |